Trimetazidine is a drug for angina pectoris sold under the brand name Vastarel MR. Trimetazidine is described as the first cytoprotective anti-ischemic agent developed and marketed by Laboratoires Servier (France).
Trimetazidine is a medicine available in a number of countries worldwide. A list of US medications equivalent to Trimetazidine is available on the Drugs.com website.
This drug is called as trimetazidine (TMZ). Also marketed as Vastarel MR in Europe, it modulates mitochondrial metabolism to energize and revive compromised heart tissue.
The CHMP was requested to give its opinion on whether the marketing authorisations for trimetazidine containing medicinal products should be maintained, varied, suspended or withdrawn.
Related topics. Trimetazidine: Wikis. Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article!
Trimetazidine is a drug for angina pectoris, sometimes referred to by the brand name Vastarel MR. Each tablet contains 35 mg of trimetazidine.Trimetazidine is an anti-ischemic (anti-anginal)...
Trimetazidine is a drug for angina pectoris sold under the brand name Vastarel MR. Trimetazidine is described as the first cytoprotective...
Trimetazidine Side Effect Report#8077912-3 Injection Site Haematoma.
Anti-ischemic cardioprotection with trimetazidine
Safety and efficacy of trimetazidine MR promise to expand the role of metabolic agents for the treatment of ischaemic heart disease.